Intra-Arterial Chemotherapy for Retinoblastoma
with Dr. Eric Monroe and Dr. Christopher Beck
Interventional Radiologist Dr. Eric Monroe from Seattle Children's walks us through Intra-Arterial Chemotherapy (IAC) for treatment of Retinoblastoma. In certain patients with retinoblastoma, IAC is a safe and effective treatment alternative to conventional systemic chemotherapy, external beam radiation, and enucleation.
Special thanks to our sponsor
BackTable, LLC (Producer). (2020, September 8). Ep. 81 – Intra-Arterial Chemotherapy for Retinoblastoma [Audio podcast]. Retrieved from
In this Episode
Dr. Eric Monroe is a practicing Interventional Radiologist with Seattle Children's in Washington.
Host Dr. Chris Beck is a practicing interventional radiologist with Regional Radiology Group in New Orleans.
In this episode, Dr. Eric Monroe joins Dr. Christopher Beck to discuss using intra-arterial chemotherapy (IAC) as a treatment for retinoblastoma. Dr. Monroe touches on how he has been using telemedicine during this time and the process of considering a patient for IAC.
We go over the details of the intra-arterial chemotherapy procedure and we mention some challenges that may arise in dealing with equipment for pediatric patients, specifically how to have a successful procedure while maintaining a low radiation dose. Dr. Monroe speaks about post procedural care including follow-up intervals and what those visits entail.
We discuss some of the common complications that can occur during intra-arterial chemotherapy. Dr. Monroe gives some advice about the mental preparation and learning curve that comes with developing skills for IAC.
A Review of the Literature for Intra-Arterial Chemotherapy used to Treat Retinoblastoma
This is the article mentioned by Dr. Monroe which gives an overview of retinoblastoma.
Disclaimer: The Materials available on the BackTable Podcast are for informational and educational purposes only and are not a substitute for the professional judgment of a healthcare professional in diagnosing and treating patients. The opinions expressed by participants of the BackTable Podcast belong solely to the participants, and do not necessarily reflect the views of BackTable.